Cargando…

Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients

BACKGROUND: mRNA COVID-19 vaccines are known to provide an immune response seen on FDG PET studies. However, the time course of this metabolic response is unknown. We here present a temporal metabolic response to mRNA COVID-19 vaccination in oncology patients undergoing standard of care FDG PET. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Advani, Pooja, Chumsri, Saranya, Pai, Tanmayi, Li, Zhuo, Sharma, Akash, Parent, Ephraim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406005/
https://www.ncbi.nlm.nih.gov/pubmed/34463888
http://dx.doi.org/10.1007/s12149-021-01675-8
_version_ 1783746434175074304
author Advani, Pooja
Chumsri, Saranya
Pai, Tanmayi
Li, Zhuo
Sharma, Akash
Parent, Ephraim
author_facet Advani, Pooja
Chumsri, Saranya
Pai, Tanmayi
Li, Zhuo
Sharma, Akash
Parent, Ephraim
author_sort Advani, Pooja
collection PubMed
description BACKGROUND: mRNA COVID-19 vaccines are known to provide an immune response seen on FDG PET studies. However, the time course of this metabolic response is unknown. We here present a temporal metabolic response to mRNA COVID-19 vaccination in oncology patients undergoing standard of care FDG PET. METHODS: 262 oncology patients undergoing standard of care FDG PET were included in the analysis. 231 patients had at least one dose of mRNA COVID-19 vaccine while 31 patients had not been vaccinated. The SUVmax of the lymph nodes ipsilateral to the vaccination was compared to the contralateral to obtain an absolute change in SUVmax (ΔSUVmax). RESULTS: ΔSUVmax was more significant at shorter times between FDG PET imaging and COVID-19 mRNA vaccination, with a median ΔSUVmax of 2.6 (0–7 days), 0.8 (8–14 days), and 0.3 (> 14 days), respectively. CONCLUSION: Consideration should be given to performing FDG PET at least 2 weeks after the COVID-19 vaccine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12149-021-01675-8.
format Online
Article
Text
id pubmed-8406005
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-84060052021-08-31 Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients Advani, Pooja Chumsri, Saranya Pai, Tanmayi Li, Zhuo Sharma, Akash Parent, Ephraim Ann Nucl Med Short Communication BACKGROUND: mRNA COVID-19 vaccines are known to provide an immune response seen on FDG PET studies. However, the time course of this metabolic response is unknown. We here present a temporal metabolic response to mRNA COVID-19 vaccination in oncology patients undergoing standard of care FDG PET. METHODS: 262 oncology patients undergoing standard of care FDG PET were included in the analysis. 231 patients had at least one dose of mRNA COVID-19 vaccine while 31 patients had not been vaccinated. The SUVmax of the lymph nodes ipsilateral to the vaccination was compared to the contralateral to obtain an absolute change in SUVmax (ΔSUVmax). RESULTS: ΔSUVmax was more significant at shorter times between FDG PET imaging and COVID-19 mRNA vaccination, with a median ΔSUVmax of 2.6 (0–7 days), 0.8 (8–14 days), and 0.3 (> 14 days), respectively. CONCLUSION: Consideration should be given to performing FDG PET at least 2 weeks after the COVID-19 vaccine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12149-021-01675-8. Springer Singapore 2021-08-31 2021 /pmc/articles/PMC8406005/ /pubmed/34463888 http://dx.doi.org/10.1007/s12149-021-01675-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Short Communication
Advani, Pooja
Chumsri, Saranya
Pai, Tanmayi
Li, Zhuo
Sharma, Akash
Parent, Ephraim
Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients
title Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients
title_full Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients
title_fullStr Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients
title_full_unstemmed Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients
title_short Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients
title_sort temporal metabolic response to mrna covid-19 vaccinations in oncology patients
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406005/
https://www.ncbi.nlm.nih.gov/pubmed/34463888
http://dx.doi.org/10.1007/s12149-021-01675-8
work_keys_str_mv AT advanipooja temporalmetabolicresponsetomrnacovid19vaccinationsinoncologypatients
AT chumsrisaranya temporalmetabolicresponsetomrnacovid19vaccinationsinoncologypatients
AT paitanmayi temporalmetabolicresponsetomrnacovid19vaccinationsinoncologypatients
AT lizhuo temporalmetabolicresponsetomrnacovid19vaccinationsinoncologypatients
AT sharmaakash temporalmetabolicresponsetomrnacovid19vaccinationsinoncologypatients
AT parentephraim temporalmetabolicresponsetomrnacovid19vaccinationsinoncologypatients